Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells

Doxorubicin (DOX) is metabolized to a variety of metabolites in vivo, which has been shown to be associated with cardiotoxicity. We speculate that metabolic processes are also present in tumor cells. A LC-MS/MS method was developed to detect intracellular metabolites. Drug resistant tumor cells with...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xu, Hui, Renjie, Chen, Yun, Wang, Wentao, Chen, Yujiao, Gong, Xiaohai, Jin, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909010/
https://www.ncbi.nlm.nih.gov/pubmed/31866863
http://dx.doi.org/10.3389/fphar.2019.01434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909010/
https://www.ncbi.nlm.nih.gov/pubmed/31866863
http://dx.doi.org/10.3389/fphar.2019.01434

Ejemplares similares